Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
Sales | 8,255,000 | 7,828,000 | 8,305,000 | 8,236,000 | 8,278,000 |
Cost of Goods | 1,819,000 | 1,694,000 | 2,022,000 | 1,835,000 | 1,934,000 |
Gross Profit | 6,436,000 | 6,134,000 | 6,283,000 | 6,401,000 | 6,344,000 |
Operating Expenses | 3,036,000 | 3,124,000 | 8,724,000 | 3,242,000 | 3,582,000 |
Operating Income | 3,400,000 | 3,010,000 | -2,441,000 | 3,159,000 | 2,762,000 |
Interest Expense | 309,000 | 325,000 | 319,000 | 302,000 | 272,000 |
Other Income | -2,284,000 | -141,000 | 387,000 | -96,000 | -478,000 |
Pre-tax Income | 807,000 | 2,544,000 | -2,373,000 | 2,761,000 | 2,012,000 |
Income Tax | 66,000 | 88,000 | -547,000 | 14,000 | 29,000 |
Net Income Continuous | 741,000 | 2,456,000 | -1,826,000 | 2,747,000 | 1,983,000 |
Net Income | $741,000 | $2,456,000 | $-1,826,000 | $2,747,000 | $1,983,000 |
EPS Basic Total Ops | 0.49 | 1.65 | -1.14 | 1.81 | 1.26 |
EPS Basic Continuous Ops | 0.50 | 1.66 | -1.14 | 1.82 | 1.26 |
EPS Diluted Total Ops | 0.49 | 1.65 | -1.15 | 1.81 | 1.26 |
EPS Diluted Continuous Ops | 0.50 | 1.66 | -1.14 | 1.81 | 1.26 |
EBITDA(a) | $3,902,000 | $3,513,000 | $-1,999,000 | $3,594,000 | $3,205,000 |